(Q44439591)

3 December 2017

title

Modifications of the catalytic and binding subunits of pertussis toxin by formaldehyde: effects on toxicity and immunogenicity (English)

1 reference

3 December 2017

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(03)00104-X

2 January 2024

author name string

Sarah Fowler

1

1 reference

3 December 2017

Dorothy K-L Xing

2

1 reference

3 December 2017

Barbara Bolgiano

3

1 reference

3 December 2017

Chun-Ting Yuen

4

1 reference

3 December 2017

Michael J. Corbel

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12744863

2 January 2024

language of work or name

English

0 references

publication date

1 June 2003

1 reference

3 December 2017

2 June 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12744863

full work available at URL

2 January 2024

https://api.elsevier.com/content/article/PII:S0264410X0300104X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(03)00104-X

https://api.elsevier.com/content/article/PII:S0264410X0300104X?httpAccept=text/plain

2 January 2024

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(03)00104-X

2 January 2024

1 reference

3 December 2017

volume

21

1 reference

3 December 2017

issue

19-20

1 reference

3 December 2017

page(s)

2329-2337

1 reference

Pertussis Toxin: The Cause of the Harmful Effects and Prolonged Immunity of Whooping Cough. A Hypothesis

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900104-X

7 January 2021

Pertussis Toxin and Extracytoplasmic Adenylate Cyclase as Virulence Factors of Bordetella pertussis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900104-X

7 January 2021

Development of a pertussis component vaccine in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900104-X

7 January 2021

Characterization of genetically inactivated pertussis toxin mutants: candidates for a new vaccine against whooping cough

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900104-X

7 January 2021

Statistical determination of the average values of the extinction coefficients of tryptophan and tyrosine in native proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900104-X

7 January 2021

Pertussis toxin gene: nucleotide sequence and genetic organization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900104-X

7 January 2021

The standardization of an assay for pertussis toxin and antitoxin in microplate culture of Chinese hamster ovary cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900104-X

7 January 2021

Detection of residual pertussis toxin in vaccines using a modified ribosylation assay

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900104-X

7 January 2021

Pertussis toxin potentiates Th1 and Th2 responses to co-injected antigen: adjuvant action is associated with enhanced regulatory cytokine production and expression of the co-stimulatory molecules B7-1, B7-2 and CD28.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900104-X

7 January 2021

Adjuvant action of cholera toxin and pertussis toxin in the induction of IgA antibody response to orally administered antigen.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900104-X

7 January 2021

The enhanced antigen-specific production of cytokines induced by pertussis toxin is due to clonal expansion of T cells and not to altered effector functions of long-term memory cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900104-X

7 January 2021

Effect of pertussis toxin on the induction of nitric oxide synthesis in murine macrophages and on protection in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900104-X

7 January 2021

Cyclic AMP is an essential factor in immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900104-X

7 January 2021

Activation of the CD3/T cell receptor (TcR) complex or of protein kinase C potentiate adenylyl cyclase stimulation in a tumoral T cell line: involvement of two distinct intracellular pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900104-X

7 January 2021

Stimulation of T-cells with OKT3 antibodies increases forskolin binding and cyclic AMP accumulation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900104-X

7 January 2021

Cholera toxin inhibits the T-cell antigen receptor-mediated increases in inositol trisphosphate and cytoplasmic free calcium

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900104-X

7 January 2021

cAMP inhibits induction of interleukin 2 but not of interleukin 4 in T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900104-X

7 January 2021

The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900104-X

7 January 2021

cAMP antagonizes interleukin 2-promoted T-cell cycle progression at a discrete point in early G1.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900104-X

7 January 2021

Augmentation of phorbol ester-induced T cell proliferation by agents which raise intracellular cyclic adenosine monophosphate

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900104-X

7 January 2021

Synergistic induction of interleukin 2 receptor (TAC) expression on YT cells by interleukin 1 or tumor necrosis factor alpha in combination with cAMP inducing agents

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900104-X

7 January 2021

Acellular pertussis vaccines: evaluation of reversion in a nude mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900104-X

7 January 2021

A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900104-X

7 January 2021

Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900104-X

7 January 2021

Novel configurations of high molecular weight species of the pertussis toxin vaccine component

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900104-X

7 January 2021

Native and Genetically Inactivated Pertussis Toxins Induce Human Dendritic Cell Maturation and Synergize with Lipopolysaccharide in Promoting T Helper Type 1 Responses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900104-X

7 January 2021

Bordetella pertussis toxin induces the release of inflammatory cytokines and dendritic cell activation in whole blood: impaired responses in human newborns

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900104-X

7 January 2021

Ceramide signalling and the immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900104-X

7 January 2021

Modulation of innate and acquired immune responses by Escherichia coli heat-labile toxin: distinct pro- and anti-inflammatory effects of the nontoxic AB complex and the enzyme activity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900104-X

7 January 2021

Properties of pertussis toxin mutant PT-9K/129G after formaldehyde treatment

4

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(03)00104-X

The reaction of bacterial toxins with formaldehyde and its use for antigen stabilization

2 January 2024

5

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(03)00104-X

Production of a safe, potent and immunogenic partially purified acellular pertussis vaccine using simple indigenous techniques

2 January 2024

7

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(03)00104-X

2 January 2024

Identifiers

1 reference

3 December 2017

1 reference